Improved Pustular Clearance, Symptom Control With Spesolimab in GPP New research suggests that spesolimab-treated patients were more likely to achieve near-complete or complete skin clearance vs placebo-treated patients.

In patients with generalized pustular psoriasis (#GPP), treatment with #Spesolimab has been associated with clinically meaningful improvements in pustular clearance and symptom control during acute disease flares.

Read here: https://bit.ly/3NGPAa7

#RareDisease #MedSky

LEO bulks up with deal for Boehringer skin drug LEO Pharma has licensed a medicine for a rare form of psoriasis from Boehringer Ingelheim, plugging a gap in its near-term product portfolio.

#dermatology #LEO #Boehringer #LEOPharma #psoriasis #BoehringerIngelheim #Spevigo #spesolimab #IL36inhibitor #psoriasisflares #generalisedpustularpsoriasis #GPP #IL36mediatedskindiseases #palmoplantarpustulosis #hidradenitissuppurativa #congenitalichthyosis
pharmaphorum.com/news/leo-bul...